EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

T-World Virtual Human Cardiomyocyte. I. Development, Validation, and Cell Arrhythmogenesis

Jakub Tomek iD, Maxx Holmes, Thomas Bury, Marketa Tomkova iD, Heeseung Jo iD, Norbert Nagy iD, Ambre Bertrand iD, Alfonso Bueno-Orovio iD, Michael A Colman iD, Blanca Rodriguez iD, Donald M Bers iD, Jordi Heijman iD

Circulation Research · 2026

DOI: 10.1161/circresaha.125.328073 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Circulation Research, 2026. Verfasst von Jakub Tomek und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Physiology and Genetics (J.T., H.J.), University of Oxford, United Kingdom. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Arrhythmias, Cardiac, Models, Cardiovascular, Computer Simulation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cardiovascular disease is the leading global cause of morbidity and mortality. New technologies are needed to improve mechanistic understanding and inform therapeutic strategies. Human-centric cardiac simulations show great promise; however, existing cellular models can reproduce only a few arrhythmia-driving behaviors and show important discrepancies with experimental data. We aimed to develop a new model overcoming this lack of generality, which markedly limits the predictivity and translational utility of virtual cardiomyocytes. METHODS: We developed T-World, a novel virtual human cardiomyocyte, using data-driven differential equations to describe sex-specific excitation-contraction coupling, mechanical contraction, β-adrenergic signaling, and its effects on cellular targets. The model contains several key innovations, including a new approach to coupling L-type calcium channels and ryanodine receptors, with updated calcium-dependent-inactivation of the former and novel calcium-induced refractoriness and complete reparameterization of the latter. We also redeveloped the sodium-potassium pump and made major improvements to the sodium-calcium exchanger formulation. RESULTS: T-World shows broad agreement with experimental data on rate-dependent action potential (AP), calcium handling, and contraction properties. Extensively validated on independent data, T-World demonstrates strong predictive performance, for example, in drug-induced AP changes. The model reproduces the effects of sympathetic stimulation, including AP duration shortening and increased calcium-transient amplitude and contractility. Importantly, it recapitulates for the first time all key cellular mechanisms driving life-threatening arrhythmias (early and delayed afterdepolarizations, alternans, and steep S1-S2 restitution), including experimentally observed responses to interventions such as sympathetic activation, SERCA (sarco/endoplasmic reticulum Ca 2+ ATPase) inhibition, and AP prolongation. Combined with the model’s ability to simulate physiological sex-specific differences in electrophysiology, this revealed increased proclivity of female cardiomyocytes to early afterdepolarizations and steep restitution of AP duration. CONCLUSIONS: T-World is a highly general and predictive open-source computer model of a human ventricular cardiomyocyte, suitable for multiscale research studies investigating determinants of arrhythmogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacArrhythmias, CardiacModels, CardiovascularComputer SimulationHumansAction PotentialsCalcium Channels, L-TypeFemaleMyocardial ContractionExcitation Contraction CouplingMaleRyanodine Receptor Calcium Release ChannelSodium-Calcium ExchangerCalcium Signaling

Stichwörter der Autor:innen

action potentialsarrhythmias, cardiaccardiovascular diseasesmorbiditymyocytes, cardiac

Substanzen

Calcium Channels, L-TypeRyanodine Receptor Calcium Release ChannelSodium-Calcium Exchanger

Autor:innen und Institutionen

  • Department of Anatomy, Physiology and Genetics (J.T., H.J.), University of Oxford, United Kingdom.
  • Department of Pharmacology, University of California, Davis (J.T., D.M.B.).
  • Department of Computer Science (M.H., A.B., A.B.-O., B.R.), University of Oxford, United Kingdom.
  • Department of Physiology, McGill University, Montreal, CA (T.B.).
  • Ludwig Cancer Research (M.T.), University of Oxford, United Kingdom.
  • Department of Pharmacology and Pharmacotherapy, University of Szeged, Hungary (N.N.).

ORCID-Profile: Jakub Tomek, Marketa Tomkova, Heeseung Jo, Norbert Nagy, Ambre Bertrand, Alfonso Bueno-Orovio, Michael A Colman, Blanca Rodriguez, Donald M Bers, Jordi Heijman

Förderung

  • Wellcome Trust
  • Medical Research Council
  • NHLBI NIH HHS

Zitieren

APA

Tomek, J., Holmes, M., Bury, T., Tomkova, M., Jo, H., Nagy, N., Bertrand, A., Bueno-Orovio, A., Colman, M. A., Rodriguez, B., Bers, D. M., & Heijman, J. (2026). T-World Virtual Human Cardiomyocyte. I. Development, Validation, and Cell Arrhythmogenesis. Circulation Research. https://doi.org/10.1161/circresaha.125.328073

Vancouver

Tomek J, Holmes M, Bury T, Tomkova M, Jo H, Nagy N, et al. T-World Virtual Human Cardiomyocyte. I. Development, Validation, and Cell Arrhythmogenesis. Circulation Research. 2026. doi:10.1161/circresaha.125.328073

BibTeX
@article{Tomek2026,
  author = {Tomek, Jakub and Holmes, Maxx and Bury, Thomas and Tomkova, Marketa and Jo, Heeseung and Nagy, Norbert and Bertrand, Ambre and Bueno-Orovio, Alfonso and Colman, Michael A and Rodriguez, Blanca and Bers, Donald M and Heijman, Jordi},
  title = {T-World Virtual Human Cardiomyocyte. I. Development, Validation, and Cell Arrhythmogenesis},
  journal = {Circulation Research},
  year = {2026},
  doi = {10.1161/circresaha.125.328073}
}
Kostenlos starten →